Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ardent Health, Inc. for alleged violations of federal securities laws related to misleading statements about the company's accounts receivable and malpractice liability insurance [2][4]. Group 1: Legal Investigation - The firm is encouraging investors who suffered losses exceeding $50,000 from purchasing Ardent securities between July 18, 2024, and November 12, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Ardent, with a deadline of March 9, 2026, for investors to seek the role of lead plaintiff [2][4]. - The complaint alleges that Ardent and its executives made false statements and failed to disclose critical information regarding the company's financials [4]. Group 2: Company Background - Ardent Health, Inc. is publicly traded on the NYSE under the ticker ARDT [2]. - The firm, Faruqi & Faruqi, has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 3: Call for Information - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Ardent's conduct [5].
ARDT SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Ardent (ARDT) Investors of the Securities Class Action Lawsuit Deadline on March 9, 2026